Clinical Trial Update: Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects [Phase 2]

View source ↗

Summary

Phase 2 open-label trial evaluating MN-001 on HDL and triglycerides in subjects with NASH/NAFLD completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hypertriglyceridemia
• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis

Drugs mentioned

• MN-001

Snippet

Sponsor: MediciNova | Conditions: Non-alcoholic Steatohepatitis, Hypertriglyceridemia | Phase 2 | Status: COMPLETED | Results posted: 2023-03-15